EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population

Daniela Jou-Valencia iD, Meint Volbeda iD, Jan G Zijlstra iD, Jenny E Kootstra-Ros iD, Jill Moser iD, Matijs van Meurs iD, Jacqueline Koeze iD

BMC Nephrology · 2024

DOI: 10.1186/s12882-024-03477-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Nephrology, 2024. Verfasst von Daniela Jou-Valencia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, Groningen, 9713GZ, The Netherlands. Hauptthemen laut MEDLINE: Cystatin C, Acute Kidney Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline of plasma levels of NGAL and CysC during the first seven days of ICU admission in a mixed ICU population and to relate these to AKI severity during ICU stay. Via these means we aimed to bring clarity to the previously reported heterogeneity of these renal biomarkers.

Methods

Prospective Observation Cohort. Consecutive patients admitted to adult ICU at an academic hospital in the Netherlands between 18-02-2014 and 31-03-2014 were included. Urine output, serum creatinine, plasma NGAL and CysC were recorded during the first seven days of ICU admission. Biomarker expression was analyzed based on KDIGO score and time of AKI diagnosis.

Results

335 patients were included, 110 met KDIGO criteria for AKI. NGAL and CysC plasma levels were higher in AKI patients compared to non-AKI, high variability in individual values resulted in 56% of AKI patients having a false negative, and 32% of non-AKI patients having a false positive. Individual biomarker levels were variable, and no pattern based on KDIGO score was observed.

Conclusions

Plasma NGAL and CysC as biomarkers for the early AKI detection may be subject to pathophysiological, and patient related heterogeneity. Further understanding of individual biomarker profiles may help in their application amongst mixed ICU populations. Trial Registration The need for informed consent was waived by the Institutional Ethical Review Board of the University Medical Center Groningen (METc 2013 − 174) by Prof. dr. W.A. Kamps on May 17th 2013.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CAcute Kidney InjuryAdultHumansLipocalin-2Prospective StudiesBiomarkersCreatinineIntensive Care Units

Stichwörter der Autor:innen

AKICystatin CHeterogeneityNGALTimeline

Substanzen

Lipocalin-2Cystatin CBiomarkersCreatinine

Autor:innen und Institutionen

  • Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, Groningen, 9713GZ, The Netherlands.
  • Department of Pathology and Medical Biology, Medical Biology section, Laboratory for Endothelial Biomedicine & Vascular Drug Targeting Research, University of Groningen, UMCG, Groningen, The Netherlands.
  • Department of Laboratory Medicine, UMCG, Groningen, The Netherlands.
  • Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, Groningen, 9713GZ, The Netherlands. j.koeze@umcg.nl.

ORCID-Profile: Daniela Jou-Valencia, Meint Volbeda, Jan G Zijlstra, Jenny E Kootstra-Ros, Jill Moser, Matijs van Meurs, Jacqueline Koeze

Zitieren

APA

Jou-Valencia, D., Volbeda, M., Zijlstra, J. G., Kootstra-Ros, J. E., Moser, J., van Meurs, M., & Koeze, J. (2024). Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population. BMC Nephrology. https://doi.org/10.1186/s12882-024-03477-2

Vancouver

Jou-Valencia D, Volbeda M, Zijlstra JG, Kootstra-Ros JE, Moser J, van Meurs M, et al. Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population. BMC Nephrology. 2024. doi:10.1186/s12882-024-03477-2

BibTeX
@article{JouValencia2024,
  author = {Jou-Valencia, Daniela and Volbeda, Meint and Zijlstra, Jan G and Kootstra-Ros, Jenny E and Moser, Jill and van Meurs, Matijs and Koeze, Jacqueline},
  title = {Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population},
  journal = {BMC Nephrology},
  year = {2024},
  doi = {10.1186/s12882-024-03477-2}
}
Kostenlos starten →